Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Skye Bioscience Inc shares valued at $582,936 were sold by Schwab Andrew J. on Aug 22 ’25. At $3.42 per share, Schwab Andrew J. sold 170,449 shares. The insider’s holdings dropped to 57,493 shares worth approximately $98887.95999999999 following the completion of this transaction.
Also, Schwab Andrew J. sold 60,956 shares, netting a total of over 217,613 in proceeds. Following the sale of shares at $3.57 each, the insider now holds 63,963 shares.
Before that, 5AM Partners VII, LLC had sold 170,449 shares from its account. In a trade valued at $582,936, the 10% Owner traded Skye Bioscience Inc shares for $3.42 each. Upon closing the transaction, the insider’s holdings decreased to 170,449 shares, worth approximately $98887.95999999999.
As published in a research note from Craig Hallum on October 06, 2025, Skye Bioscience Inc [SKYE] has been rated down from a Buy to a Hold and the price target has been revised to $2. Analysts at Cantor Fitzgerald downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in early October. As of August 15, 2025, Evercore ISI has initiated its “an Outperform” rating for SKYE. Earlier on February 28, 2025, William Blair initiated its rating. Their recommendation was “an Outperform” for SKYE stock.
Analyzing SKYE Stock Performance
On last trading session, Skye Bioscience Inc [NASDAQ: SKYE] rose 3.61% to $1.72. The stock’s lowest price that day was $1.7006, but it reached a high of $1.8137 in the same session. During the last five days, there has been a drop of approximately -59.62%. Over the course of the year, Skye Bioscience Inc shares have dropped approximately -51.55%. Shares of the company reached a 52-week high of $5.7500 on 06/27/25 and a 52-week low of $1.1400 on 04/08/25.
Support And Resistance Levels for Skye Bioscience Inc (SKYE)
According to the 24-hour chart, there is a support level at 1.6754, which, if violated, would cause prices to drop to 1.6309. In the upper region, resistance lies at 1.7891. The next price resistance is at 1.8583. RSI (Relative Strength Index) is 29.00 on the 14-day chart, showing oversold technical sentiment.
Is Skye Bioscience Inc subject to short interest?
Stocks of Skye Bioscience Inc saw a sharp rise in short interest on 2025-09-15 jumping by 76516.0 shares to 2.75 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 2.67 million shares. A jump of 2.79% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.84 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.84.
Which companies own the most shares of Skye Bioscience Inc (SKYE)?
In terms of Skye Bioscience Inc share price expectations, FactSet research, analysts set an average price target of 2 in the next 12 months, up nearly 20.48% from the previous closing price of $1.66. Analysts anticipate Skye Bioscience Inc stock to reach 2 by 2025, with the lowest price target being 2. In spite of this, 3 analysts ranked Skye Bioscience Inc stock as Buy at the end of 2025. On September 30, 2024, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $20.
